Table 1 Dosing regimens responses for CRS, ARS, SSNHL, and IFN/Bell’s Palsy. This table shows the use of OCSs, number of unique dosing regimens reported, median starting dose, average duration, and taper utilization for CRSwP, CRSsP, ARS, SSNHL, and IFN
From: Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons
Indication | Use (% of respondents) | Unique dosing regimens | Median dose with ranges | Duration with ranges | Taper (% of respondents) |
|---|---|---|---|---|---|
CRSwP | 79 | 12 | 50 (10–100) | 8 (1–21) | 64 |
CRSsP | 23 | 7 | 50 (20–80) | 8 (1–14) | 62 |
ARS | 7 | 9 | 50 (25–60) | 6 (2–10) | 44 |
SSNHL | 95 | 11 | 55 (10–120) | 10 (1–21) | 60 |
IFN/Bell’s Palsy | 87 | 9 | 50 (10–100) | 9 (1–21) | 53 |